Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial

Ritesh Patil, Guy T. Clifton, Jarrod P. Holmes, Asna Amin, Mark G. Carmichael, Jeremy D. Gates, Linda H. Benavides, Matthew T. Hueman, Sathibalan Ponniah, George E. Peoples

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Clinical and Immunologic Responses of HLA-A3<sup>+</sup> Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences